Skip to main content
Intended for healthcare professionals

Antiviral Therapy is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases. The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research. View full journal description

Browse by

Articles most recently published online for this journal.
Open Access
Research article
First published  

Harnessing SuperNatural database to identify VP35 inhibitors as anti-Ebola drug candidates: A multistage In silico study

  • Abeer A. M. Hasb
  • Gamal A. H. Mekhemer
  • Peter A. Sidhom
  • Ahmed Rady
  • Yanshuo Han
  • Mahmoud A. A. Ibrahim
Open Access
Research article
First published  

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection

  • Yacine Abed
  • Chantal Rhéaume
  • Julie Carbonneau
  • Nicolas Fortin
  • René Maltais
  • André Marette
  • Donald Poirier
  • Guy Boivin
Open Access
Research article
First published  

A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants

  • Ed Gane
  • Christian Schwabe
  • Min Wu
  • Tse-I Lin
  • Lawrence Blatt
  • John Fry
  • Sushmita Chanda
  • Kha Le
Open Access
Case report
First published  

Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro efficacy of intravenous immunoglobulins and remdesivir: Case report

  • Emma M. de Koff
  • Harmen van Andel
  • Hanna K. de Jong
  • Anneke J. van der Kooi
  • Carlemi Calitz
  • Gerrit Koen
  • Arjan J. Kwakernaak
  • Katja C. Wolthers
View latest issues
Most read articles in this journal in the last 6 months.
Open Access
Review article
First published  

Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines

  • Markus Cornberg
  • Fabien Zoulim
  • Robert Gish
  • Ira M. Jacobson
  • Tatyana Kushner
  • Pietro Lampertico
  • Mario Rizzetto
  • Cihan Yurdaydin
  • Michael Manns
Open Access
Review article
First published  

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective

  • Andrew Carr
  • Nicola E Mackie
  • Roger Paredes
  • Kiat Ruxrungtham
Open Access
Case report
First published  

Enterovirus-associated deafness and myositis in an immunocompromised patient with in vivo and in vitro efficacy of intravenous immunoglobulins and remdesivir: Case report

  • Emma M. de Koff
  • Harmen van Andel
  • Hanna K. de Jong
  • Anneke J. van der Kooi
  • Carlemi Calitz
  • Gerrit Koen
  • Arjan J. Kwakernaak
  • Katja C. Wolthers
Open Access
Review article
First published  

A review of photodynamic therapy for the treatment of viral skin diseases

  • Joanna Bartosińska
  • Dorota Kowalczuk
  • Paulina Szczepanik-Kułak
  • Mirosław Kwaśny
  • Dorota Krasowska
View all
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Open Access
Review article
First published  

HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective

  • Andrew Carr
  • Nicola E Mackie
  • Roger Paredes
  • Kiat Ruxrungtham
Open Access
Review article
First published  

Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives

  • Quratulain Maqsood
  • Aleena Sumrin
  • Maryam Iqbal
  • Saima Younas
  • Nazim Hussain
  • Muhammada Mahnoor
  • Abdul Wajid
Open Access
Research article
First published  

Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA

  • Nicolas Margot
  • Nina Pennetzdorfer
  • Vidula Naik
  • Martin Rhee
  • Christian Callebaut
Open Access
Research article
First published  

Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach

  • Eslam B Elkaeed
  • Bshra A Alsfouk
  • Tuqa H Ibrahim
  • Reem K Arafa
  • Hazem Elkady
  • Ibrahim M Ibrahim
  • Ibrahim H Eissa
  • Ahmed M Metwaly
View all
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
Published Special Collections

You might be interested in

Publish with us

Authors will enjoy:

  • Rigorous peer review of your research
  • Prompt publishing
  • Multidisciplinary audience
  • High visibility for global exposure
Submit Now

Learn about our special collections

Explore and submit your paper to one of our Special Collections.

If you would like to curate your own Special Collection, read through our guidelines for Guest Editors and apply via our proposal form.

Information for Authors, Editors, and Reviewers

Sage supports authors, editors, and reviewers throughout all steps of the publishing process. Explore our resources:

Open access

Antiviral Therapy will be fully open access from the start of 2022. To facilitate this transition, all accepted papers first submitted on or after 6th December 2021 will be subject to an introductory APC of $1000.
Read More

Join our editorial review board

Help us recognise and reward the hard work of peer reviewers.

Receive APC discounts and gain invaluable academic experience.

Find out more and apply to join today.

Learn More

Open your research with confidence

Discover more about Sage Gold Open Access including our Special Collections and flagship titles. From endocrinology to ethnography, we publish a broad range of over 200 journals.
Learn More

Also from Sage